| CAS NO: | 110429-45-3 |
| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 1 g | 电议 |
| 5 g | 电议 |
| 生物活性 | m-PEG4-Br is acleavableADC linkerused in the synthesis of antibody-drug conjugate (ADC) for Trastuzumab (HY-P9907). m-PEG4-Br is placed distally from the monomethylauristatinE (MMAE) payload to yield an ADC with altered hydrophilicity, antigen binding, and in vitro potency[1]. m-PEG4-Br also can be used as aPROTAClinker that can be used in the synthesis ofPROTACs. | ||||||||||||
| IC50& Target[1] |
| ||||||||||||
| 体外研究 (In Vitro) | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. | ||||||||||||
| 分子量 | 271.15 | ||||||||||||
| 性状 | Liquid | ||||||||||||
| Formula | C9H19BrO4 | ||||||||||||
| CAS 号 | 110429-45-3 | ||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| 储存方式 |
|
m.cnreagent.com